EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A pilot study of gut mucosal and faecal microbiota in rectal cancer: associations with histological response and adverse events following preoperative chemoradiotherapy

Shigenobu Emoto iD, Ryo Inoue, Shin Murai, Yuriko Inagaki, Hiroaki Nozawa, Kazuhito Sasaki, Koji Murono iD, Kensuke Kaneko, Yuichiro Yokoyama, Shinya Abe, Yuzo Nagai, Takahide Shinagawa und 7 weitere

Colorectal Disease · 2025-05 · 27 (5)

DOI: 10.1111/codi.70106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colorectal Disease, 2025-05. Verfasst von Shigenobu Emoto und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Rectal Neoplasms, Gastrointestinal Microbiome, Feces, Intestinal Mucosa. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Preoperative chemoradiotherapy (CRT) is administered for locally advanced rectal cancer (LARC); however, its efficacy and toxicity vary among patients. This study aimed to elucidate the relationship between the gut microbiota and the effectiveness and adverse events of CRT.

Methods

This prospective study included 21 patients with LARC with no history of antibiotic or probiotic administration for 6 months. Tumour mucosa, non‐tumour mucosa and faecal samples were collected before and after CRT, and bacterial DNA was extracted. Metataxonomic analysis targeting the V3 and V4 regions of the 16S rRNA gene was conducted to determine the diversity and composition of the microbiota. Linear discriminant analysis effect size (LEfSe) was used to explore potential bacterial taxa predicting pathological complete response (pCR) and treatment‐associated diarrhoea, which are major adverse events of CRT.

Results

Among the 21 patients, five achieved pCR and seven experienced severe treatment‐associated diarrhoea. There were no significant differences in α‐diversity and β‐diversity of the microbiota between the groups at any sampling sites before or after CRT . Exploratory analysis using LEfSe identified Peptostreptococcus , Coprococcus and Phoceaicola in the tumour mucosa before CRT as significant indicators for achieving pCR . Additionally, Collinsella , Haemophilus and Desulfovibrionaceae are associated with treatment‐associated diarrhoea. Microbiome composition changed before and after CRT , with a notable decrease in the genus Fusobacterium_C and other taxa. β‐diversity in the tumour area also changed significantly ( P = 0.03).

Conclusions

This study suggests an association between the gut microbiota, the therapeutic effectiveness of CRT and the occurrence of treatment‐associated diarrhoea in rectal cancer. These results indicate the potential for predicting treatment efficacy and adverse events based on the microbiota composition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsGastrointestinal MicrobiomeFecesIntestinal MucosaChemoradiotherapyHumansMaleFemalePilot ProjectsMiddle AgedProspective StudiesAgedTreatment OutcomeNeoadjuvant TherapyDiarrheaRNA, Ribosomal, 16S

Stichwörter der Autor:innen

chemoradiotherapymicrobiotamucosal microbiomepathological complete responserectal cancertreatment‐associated diarrhoea

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Surgical Oncology, University of Tokyo, Tokyo, Japan.
  • Laboratory of Animal Science, Setsunan University, Hirakata, Japan.
  • Kyoto Institute of Nutrition and Pathology, Ujitawara, Japan.
  • Department of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.

ORCID-Profile: Shigenobu Emoto, Koji Murono

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Emoto, S., Inoue, R., Murai, S., Inagaki, Y., Nozawa, H., Sasaki, K., Murono, K., Kaneko, K., Yokoyama, Y., Abe, S., Nagai, Y., Shinagawa, T., Tachikawa, Y., Okada, S., Tsukahara, T., Ohashi, K., Ohno, M., Andoh, A., & Ishihara, S. (2025). A pilot study of gut mucosal and faecal microbiota in rectal cancer: associations with histological response and adverse events following preoperative chemoradiotherapy. Colorectal Disease, 27(5). https://doi.org/10.1111/codi.70106

Vancouver

Emoto S, Inoue R, Murai S, Inagaki Y, Nozawa H, Sasaki K, et al. A pilot study of gut mucosal and faecal microbiota in rectal cancer: associations with histological response and adverse events following preoperative chemoradiotherapy. Colorectal Disease. 2025;27(5). doi:10.1111/codi.70106

BibTeX
@article{Emoto2025,
  author = {Emoto, Shigenobu and Inoue, Ryo and Murai, Shin and Inagaki, Yuriko and Nozawa, Hiroaki and Sasaki, Kazuhito and Murono, Koji and Kaneko, Kensuke and Yokoyama, Yuichiro and Abe, Shinya and Nagai, Yuzo and Shinagawa, Takahide and Tachikawa, Yuichi and Okada, Satoshi and Tsukahara, Takamitsu and Ohashi, Kai and Ohno, Masashi and Andoh, Akira and Ishihara, Soichiro},
  title = {A pilot study of gut mucosal and faecal microbiota in rectal cancer: associations with histological response and adverse events following preoperative chemoradiotherapy},
  journal = {Colorectal Disease},
  year = {2025},
  volume = {27},
  number = {5},
  doi = {10.1111/codi.70106}
}
Kostenlos starten →